AbbVie reaches deal with Trump administration on drug prices


Chicago Tribune

AbbVie reaches deal with Trump administration on drug prices in exchange for tariff relief

North Chicago-based AbbVie has become the latest drugmaker to reach a deal with the Trump administration on drug prices in exchange for being exempted from tariffs and future price mandates, the company announced Monday evening.

Read Story

Related articles:

AbbVie to invest $195 million in North Chicago facility that will produce active pharmaceutical ingredients

Comments

Popular posts from this blog

La Grange restaurant expansion turns into reality series

The Morning: Your best advice of 2024

The Morning: Electoral wishcasting